\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	the\\ initial\\ exam\\ revealed\\ small\\ almost\\ guttate\\ lesions\\ of\\ erythema\\ and\\ scale\\ with\\ follicular\\ prominence\\ scattered\\ over\\ his\\ back\\,\\ shoulders\\,\\ and\\ anterior\\ chest\\.\\ these\\ lesions\\ progressed\\ to\\ involve\\ his\\ upper\\ arms\\,\\ abdomen\\,\\ thighs\\,\\ and\\ lower\\ legs\\.\\ later\\ examination\\ revealed\\ annular\\ patches\\ measuring\\ from\\ 1\\-5\\ cm\\ scattered\\ among\\ the\\ smaller\\ lesions\\,\\ with\\ the\\ periphery\\ of\\ these\\ patches\\ and\\ intervening\\ skin\\ demonstrating\\ prominent\\ follicular\\ hyperkeratosis\\.\ \(0\)\
\-\ laboratory\\:\ \(3\)\
\-\ first\\ fungal\\ culture\\:\\ scopulariopsis\\ \\(considered\\ to\\ be\\ a\\ contaminant\\)\\.\\ \ \(0\)\
\-\ second\\ fungal\\ culture\\:\\ negative\\.\ \(0\)\
\-\ third\\ fungal\\ culture\\ \\(done\\ on\\ tissue\\)\\:\\ negative\\.\ \(0\)\
\-\ rpr\\ and\\ hiv\\ negative\\,\\ cbc\\ and\\ chemistries\\ normal\\,\\ ua\\ normal\\.\ \(0\)\
\-\ histopathology\\:\\	sections\\ demonstrated\\ psoriasiform\\ epidermal\\ hyperplasia\\ with\\ hyperkeratosis\\,\\ parakeratosis\\,\\ and\\ follicular\\ keratotic\\ plugging\\.\\ there\\ was\\ minimal\\ dermal\\ inflammation\\.\ \(0\)\
\-\ the\\ patient\\ was\\ started\\ on\\ accutane\\,\\ 80mg\\/day\\ and\\ after\\ one\\ month\\ showed\\ no\\ improvement\\.\\ the\\ patient\\ was\\ not\\ able\\ to\\ tolerate\\ lachydrin\\ lotion\\ because\\ of\\ the\\ stinging\\ sensation\\.\\ the\\ patient\\ is\\ currently\\ on\\ accutane\\ 160\\ mg\\/day\\.\ \(0\)\
\-\ pityriasis\\ rubra\\ pilaris\\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#3\\)\\ presented\\ by\\:\\ rinna\\ c\\.\\ johnson\\,\\ maj\\,\\ mc\\,\\ usa\ \(0\)\
\-\ patient\\ presented\\ with\\ a\\ 3\\-4\\ year\\ history\\ of\\ a\\ chest\\ and\\ back\\ rash\\ that\\ had\\ been\\ treated\\ with\\ topical\\ selsun\\ and\\ antifungals\\ without\\ improvement\\.\\ due\\ to\\ a\\ new\\ crop\\ of\\ lesions\\ on\\ his\\ upper\\ arms\\ and\\ thighs\\,\\ he\\ sought\\ a\\ new\\ consultation\\ with\\ dermatology\\.\\ initial\\ koh\\ was\\ positive\\ and\\ the\\ patient\\ was\\ treated\\ with\\ a\\ 2\\ week\\ course\\ of\\ oral\\ ketoconazole\\ but\\ with\\ no\\ improvement\\.\\ the\\ first\\ fungal\\ culture\\ grew\\ out\\ scopulariopsis\\ ssp\\ and\\ a\\ shave\\ biopsy\\ showed\\ a\\ psoriasiform\\ dermatitis\\ with\\ negative\\ pas\\ stain\\.\\ because\\ of\\ persistence\\ of\\ lesions\\,\\ the\\ patient\\ was\\ recultured\\ 2\\ weeks\\ after\\ the\\ last\\ ketoconazole\\ and\\ this\\ second\\ culture\\ was\\ negative\\.\\ while\\ awaiting\\ culture\\ results\\,\\ the\\ patient\\ was\\ treated\\ with\\ an\\ empiric\\ course\\ of\\ oral\\ itraconazole\\.\\ the\\ patient\\ developed\\ new\\ lesions\\ while\\ on\\ itraconazole\\,\\ so\\ a\\ 4\\ mm\\ punch\\ biopsy\\ was\\ performed\\ which\\ showed\\ findings\\ suggestive\\ of\\ small\\ plaque\\ parapsoriasis\\.\\ the\\ patient\\ was\\ started\\ on\\ uvb\\ therapy\\ and\\ topical\\ kenalog\\ spray\\.\\ the\\ uvb\\ therapy\\ was\\ discontinued\\ due\\ to\\ noncompliance\\ because\\ of\\ college\\ classes\\ and\\ work\\.\\ he\\ showed\\ no\\ improvement\\ with\\ this\\ therapy\\.\\ when\\ patches\\ began\\ to\\ enlarge\\,\\ an\\ incisional\\ biopsy\\ was\\ performed\\ which\\ showed\\ changes\\ consistent\\ with\\ pityriasis\\ rubra\\ pilaris\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ culture\\:\\ 0\\.06504055067035976\ \(0\)\
\-\ patches\\:\\ 0\\.045218655529846406\ \(0\)\
\-\ scopulariopsis\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ psoriasiform\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ pilaris\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ uvb\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ follicular\\:\\ 0\\.04026760424013252\ \(0\)\
\-\ fungal\\:\\ 0\\.0394541865667104\ \(0\)\
\-\ accutane\\:\\ 0\\.03867795830193597\ \(0\)\
\-\ pityriasis\\:\\ 0\\.03867795830193597\ \(0\)\
\-\ rubra\\:\\ 0\\.03867795830193597\ \(0\)\
\-\ ketoconazole\\:\\ 0\\.03867795830193597\ \(0\)\
\-\ improvement\\:\\ 0\\.03797337796823046\ \(0\)\
\-\ hyperkeratosis\\:\\ 0\\.03431466910253523\ \(0\)\
\-\ showed\\:\\ 0\\.033354800808615435\ \(0\)\
\-\ lesions\\:\\ 0\\.03267943580491354\ \(0\)\
\-\ itraconazole\\:\\ 0\\.03207655658231744\ \(0\)\
\-\ negative\\:\\ 0\\.030382382873510406\ \(0\)\
\-\ thighs\\:\\ 0\\.02976461460240458\ \(0\)\
\-\ was\\:\\ 0\\.028236500634676764\ \(0\)\
\-\ topical\\:\\ 0\\.0277132673829167\ \(0\)\
\-\ arms\\:\\ 0\\.022726034076818804\ \(0\)\
\-\ dermatology\\:\\ 0\\.021956313355121587\ \(0\)\
\-\ biopsy\\:\\ 0\\.02165495172597686\ \(0\)\
\-\ because\\:\\ 0\\.021353702261328912\ \(0\)\
\-\ new\\:\\ 0\\.021269914120003987\ \(0\)\
\-\ contaminant\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ keratotic\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ 80mg\\/day\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ lachydrin\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ stinging\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ selsun\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ crop\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ koh\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ ssp\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ recultured\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ parapsoriasis\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ noncompliance\\:\\ 0\\.02098932958087262\ \(0\)\
\-\ guttate\\:\\ 0\\.019338979150967984\ \(0\)\
\-\ parakeratosis\\:\\ 0\\.019338979150967984\ \(0\)\
\-\ mg\\/day\\:\\ 0\\.019338979150967984\ \(0\)\
\-\ rinna\\:\\ 0\\.019338979150967984\ \(0\)\
\-\ kenalog\\:\\ 0\\.019338979150967984\ \(0\)\
\-\ spray\\:\\ 0\\.019338979150967984\ \(0\)\
\-\ scattered\\:\\ 0\\.018948745319119147\ \(0\)\
\-\ \\:\\:\\ 0\\.01883791359984442\ \(0\)\
\-\ lotion\\:\\ 0\\.018373586036424736\ \(0\)\
\-\ patient\\:\\ 0\\.018355541376779742\ \(0\)\
\-\ treated\\:\\ 0\\.018270363114884707\ \(0\)\
\-\ started\\:\\ 0\\.018150343419147806\ \(0\)\
\-\ johnson\\:\\ 0\\.017688628721063353\ \(0\)\
\-\ shave\\:\\ 0\\.017688628721063353\ \(0\)\
\-\ his\\:\\ 0\\.01759206448319237\ \(0\)\
\-\ chemistries\\:\\ 0\\.017157334551267615\ \(0\)\
\-\ antifungals\\:\\ 0\\.017157334551267615\ \(0\)\
\-\ oral\\:\\ 0\\.017145631744559586\ \(0\)\
\-\ 1\\-5\\:\\ 0\\.016723235606520104\ \(0\)\
\-\ classes\\:\\ 0\\.016723235606520104\ \(0\)\
\-\ pas\\:\\ 0\\.016356210178359965\ \(0\)\
\-\ incisional\\:\\ 0\\.016356210178359965\ \(0\)\
\-\ therapy\\:\\ 0\\.016318862830290094\ \(0\)\
\-\ intervening\\:\\ 0\\.015757842491976856\ \(0\)\
\-\ empiric\\:\\ 0\\.015757842491976856\ \(0\)\
\-\ second\\:\\ 0\\.015629185405899897\ \(0\)\
\-\ punch\\:\\ 0\\.015506984121362984\ \(0\)\
\-\ course\\:\\ 0\\.015354911635503055\ \(0\)\
\-\ rpr\\:\\ 0\\.015072885176615472\ \(0\)\
\-\ 160\\:\\ 0\\.015072885176615472\ \(0\)\
\-\ sought\\:\\ 0\\.014705859748455334\ \(0\)\
\-\ college\\:\\ 0\\.014705859748455334\ \(0\)\
\-\ enlarge\\:\\ 0\\.014705859748455334\ \(0\)\
\-\ discontinued\\:\\ 0\\.014541591006819734\ \(0\)\
\-\ plugging\\:\\ 0\\.014387927861254089\ \(0\)\
\-\ maj\\:\\ 0\\.014387927861254089\ \(0\)\
\-\ usa\\:\\ 0\\.014107492062072225\ \(0\)\
\-\ dermatitis\\:\\ 0\\.014107492062072225\ \(0\)\
\-\ epidermal\\:\\ 0\\.013978760582857283\ \(0\)\
\-\ tolerate\\:\\ 0\\.013978760582857283\ \(0\)\
\-\ awaiting\\:\\ 0\\.013740466633912084\ \(0\)\
\-\ first\\:\\ 0\\.013654683022789774\ \(0\)\
\-\ dermal\\:\\ 0\\.013629704691924245\ \(0\)\
\-\ sections\\:\\ 0\\.013523867161993688\ \(0\)\
\-\ persistence\\:\\ 0\\.013523867161993688\ \(0\)\
\-\ initial\\:\\ 0\\.01348372449180623\ \(0\)\
\-\ back\\:\\ 0\\.013424125406416559\ \(0\)\
\-\ grew\\:\\ 0\\.013142098947528975\ \(0\)\
\-\ revealed\\:\\ 0\\.013059399475552826\ \(0\)\
\-\ \\,\\:\\ 0\\.012890955500823208\ \(0\)\
\-\ while\\:\\ 0\\.01280309161834435\ \(0\)\
\-\ annular\\:\\ 0\\.01259323309369128\ \(0\)\
\-\ stain\\:\\ 0\\.012524215148754963\ \(0\)\
\-\ rash\\:\\ 0\\.012391905979338747\ \(0\)\
\-\ shoulders\\:\\ 0\\.01232841015295265\ \(0\)\
\-\ plaque\\:\\ 0\\.01226656375675441\ \(0\)\
\-\ among\\:\\ 0\\.012090116204007453\ \(0\)\
\-\ prominence\\:\\ 0\\.012034091210173656\ \(0\)\
\-\ mc\\:\\ 0\\.011925847462371856\ \(0\)\
\-\ 3\\-4\\:\\ 0\\.011925847462371856\ \(0\)\
\-\ progressed\\:\\ 0\\.01177218431680621\ \(0\)\
\-\ c\\.\\:\\ 0\\.01177218431680621\ \(0\)\
\-\ scale\\:\\ 0\\.01162783997914803\ \(0\)\
\-\ 1997\\:\\ 0\\.011405158888646068\ \(0\)\
\-\ periphery\\:\\ 0\\.011363017038409402\ \(0\)\
\-\ histopathology\\:\\ 0\\.011363017038409402\ \(0\)\
\-\ consultation\\:\\ 0\\.011363017038409402\ \(0\)\
\-\ he\\:\\ 0\\.011353273057300094\ \(0\)\
\-\ performed\\:\\ 0\\.011345611101082472\ \(0\)\
\-\ seminar\\:\\ 0\\.011321608127190666\ \(0\)\
\-\ hiv\\:\\ 0\\.011280907095382807\ \(0\)\
\-\ uniformed\\:\\ 0\\.011201534666174255\ \(0\)\
\-\ presented\\:\\ 0\\.011092179214392426\ \(0\)\
\-\ legs\\:\\ 0\\.011013961147476364\ \(0\)\
\-\ services\\:\\ 0\\.010978156677560793\ \(0\)\
\-\ due\\:\\ 0\\.010858462633108761\ \(0\)\
\-\ ua\\:\\ 0\\.010806791202262961\ \(0\)\
\-\ these\\:\\ 0\\.010589736628370669\ \(0\)\
\-\ on\\:\\ 0\\.010341300176648973\ \(0\)\
\-\ began\\:\\ 0\\.010302100129129426\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.01002463866185335\ \(0\)\
\-\ erythema\\:\\ 0\\.010000947397917235\ \(0\)\
\-\ smaller\\:\\ 0\\.0098635466416776\ \(0\)\
\-\ almost\\:\\ 0\\.009841398087719711\ \(0\)\
\-\ upper\\:\\ 0\\.009819430977946278\ \(0\)\
\-\ chest\\:\\ 0\\.00973680476217866\ \(0\)\
\-\ involve\\:\\ 0\\.00959053971710584\ \(0\)\
\-\ able\\:\\ 0\\.00959053971710584\ \(0\)\
\-\ work\\:\\ 0\\.009531747782366859\ \(0\)\
\-\ small\\:\\ 0\\.00937416802086247\ \(0\)\
\-\ sensation\\:\\ 0\\.009345641180344632\ \(0\)\
\-\ so\\:\\ 0\\.009257773187641176\ \(0\)\
\-\ cbc\\:\\ 0\\.009091205119529485\ \(0\)\
\-\ exam\\:\\ 0\\.008939209237854944\ \(0\)\
\-\ demonstrating\\:\\ 0\\.008832316547775994\ \(0\)\
\-\ 2\\:\\ 0\\.008762402364335935\ \(0\)\
\-\ last\\:\\ 0\\.008692220119149963\ \(0\)\
\-\ suggestive\\:\\ 0\\.008692220119149963\ \(0\)\
\-\ inflammation\\:\\ 0\\.008651749699224795\ \(0\)\
\-\ a\\:\\ 0\\.00849856718182717\ \(0\)\
\-\ done\\:\\ 0\\.008434568727149408\ \(0\)\
\-\ after\\:\\ 0\\.008419053345758107\ \(0\)\
\-\ prominent\\:\\ 0\\.008350596968012604\ \(0\)\
\-\ considered\\:\\ 0\\.00821319621177297\ \(0\)\
\-\ results\\:\\ 0\\.00821319621177297\ \(0\)\
\-\ third\\:\\ 0\\.00815820641464285\ \(0\)\
\-\ measuring\\:\\ 0\\.008136561243925585\ \(0\)\
\-\ currently\\:\\ 0\\.008062316178600136\ \(0\)\
\-\ minimal\\:\\ 0\\.008010666596192376\ \(0\)\
\-\ \\#\\:\\ 0\\.007980206235573543\ \(0\)\
\-\ developed\\:\\ 0\\.007833489249606463\ \(0\)\
\-\ skin\\:\\ 0\\.007814592702949949\ \(0\)\
\-\ which\\:\\ 0\\.007595926605916899\ \(0\)\
\-\ laboratory\\:\\ 0\\.007497837466319206\ \(0\)\
\-\ mm\\:\\ 0\\.007481417039988109\ \(0\)\
\-\ later\\:\\ 0\\.007346234859506962\ \(0\)\
\-\ week\\:\\ 0\\.006909560519829115\ \(0\)\
\-\ and\\:\\ 0\\.006857485932655942\ \(0\)\
\-\ out\\:\\ 0\\.006723937802044087\ \(0\)\
\-\ positive\\:\\ 0\\.006602108548295516\ \(0\)\
\-\ normal\\:\\ 0\\.006379106926662386\ \(0\)\
\-\ examination\\:\\ 0\\.006324816751129918\ \(0\)\
\-\ no\\:\\ 0\\.0061460296478843\ \(0\)\
\-\ month\\:\\ 0\\.0061038441447633564\ \(0\)\
\-\ to\\:\\ 0\\.006100972977756946\ \(0\)\
\-\ abdomen\\:\\ 0\\.006027105387846897\ \(0\)\
\-\ demonstrated\\:\\ 0\\.005970047577278494\ \(0\)\
\-\ changes\\:\\ 0\\.005831066610083478\ \(0\)\
\-\ when\\:\\ 0\\.005826979137180967\ \(0\)\
\-\ weeks\\:\\ 0\\.005774470849764639\ \(0\)\
\-\ 4\\:\\ 0\\.005668980726616775\ \(0\)\
\-\ an\\:\\ 0\\.0056269755442129995\ \(0\)\
\-\ been\\:\\ 0\\.0055352259272952176\ \(0\)\
\-\ one\\:\\ 0\\.00551364615073963\ \(0\)\
\-\ cm\\:\\ 0\\.0054570383757547285\ \(0\)\
\-\ anterior\\:\\ 0\\.005239982913720804\ \(0\)\
\-\ over\\:\\ 0\\.00518010140509515\ \(0\)\
\-\ \\(\\:\\ 0\\.005159726616027575\ \(0\)\
\-\ \\)\\:\\ 0\\.0050966978008093215\ \(0\)\
\-\ physical\\:\\ 0\\.004991679213288663\ \(0\)\
\-\ consistent\\:\\ 0\\.004988805401979056\ \(0\)\
\-\ the\\:\\ 0\\.004937474453700921\ \(0\)\
\-\ tissue\\:\\ 0\\.004822431401077605\ \(0\)\
\-\ without\\:\\ 0\\.004790507538948001\ \(0\)\
\-\ 3\\:\\ 0\\.00476422744453938\ \(0\)\
\-\ this\\:\\ 0\\.004576843872924443\ \(0\)\
\-\ lower\\:\\ 0\\.004575862069913959\ \(0\)\
\-\ case\\:\\ 0\\.004451201030636359\ \(0\)\
\-\ had\\:\\ 0\\.004390118617239782\ \(0\)\
\-\ but\\:\\ 0\\.004339293573889375\ \(0\)\
\-\ findings\\:\\ 0\\.004330564132833238\ \(0\)\
\-\ that\\:\\ 0\\.0035142398299019607\ \(0\)\
\-\ by\\:\\ 0\\.0033877878648687497\ \(0\)\
\-\ with\\:\\ 0\\.003342976459711135\ \(0\)\
\-\ be\\:\\ 0\\.0031375160079617362\ \(0\)\
\-\ of\\:\\ 0\\.0030512900208996972\ \(0\)\
\-\ there\\:\\ 0\\.003027894182059497\ \(0\)\
\-\ from\\:\\ 0\\.003015323126557649\ \(0\)\
\-\ not\\:\\ 0\\.0029400444565284177\ \(0\)\
\-\ history\\:\\ 0\\.002810034613588294\ \(0\)\
\-\ year\\:\\ 0\\.002276441117316464\ \(0\)\
\-\ \\.\\:\\ 0\\.001944022214854677\ \(0\)\
\-\ is\\:\\ 0\\.0013387875675826802\ \(0\)\
